Bcgm Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Bcgm Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $582,972 - $656,601	-10,100 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $23,863 - $29,902	412 Added 4.25%	10,100 $600,000
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $24,135 - $27,394	372 Added 3.99%	9,688 $703,000
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $52,121 - $56,233	770 Added 9.01%	9,316 $604,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $55,917 - $61,097	881 Added 11.49%	8,546 $584,000
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $91,800 - $104,743	1,530 Added 24.94%	7,665 $509,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $347,547 - $396,014	6,135 New	6,135 $410,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bcgm Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bcgm Wealth Management, LLC with notifications on news.